SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Alexander Biederstädt(The University of Texas MD Anderson Cancer Center), Ulrich Keller(Humboldt-Universität zu Berlin), Anna Katharina Scherger(TUM Klinikum), Matthias Wirth(German Cancer Research Center), Markus Schick(Humboldt-Universität zu Berlin), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung), Ying‐Fen Hong(TUM Klinikum), Gerrit Siegers(TUM Klinikum), Christian Schneeweis(TUM Klinikum), Felix Orben(TUM Klinikum), Stefan Müller(Goethe University Frankfurt), Kathrin Schunck(Goethe University Frankfurt), Jolanta Slawska(TUM Klinikum), Jonas A. Nilsson(The University of Western Australia), Alexander Muckenhuber(Technical University of Munich), Zonera Hassan(TUM Klinikum), H-P Lenhof(Saarland University), Maximilian Reichert(TUM Klinikum), Steven Langston(Millennium Engineering and Integration (United States)), Zahra Dantes(TUM Klinikum), Roland Rad(ING Direct), Günter Schneider(TUM Klinikum), Lisa M. Nilsson(Sahlgrenska University Hospital), Dieter Saur(German Cancer Research Center), Andrea Coluccio(Medigene (Germany)), Lara Schneider(Saarland University), Katja Steiger(Technical University of Munich)
Cited by 100
Related Papers
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727